LifeTech Scientific Corporation (HKG:1302)

Market Cap	8.80B +25.9%
Revenue (ttm)	1.52B +5.1%
Net Income	164.50M -33.5%
EPS	0.04 -35.0%
Shares Out	4.63B
PE Ratio	51.74
Forward PE	16.54
Dividend	n/a
Ex-Dividend Date	n/a

Volume	14,320,000
Average Volume	20,015,225
Open	1.900
Previous Close	1.900
Day's Range	1.890 - 1.960
52-Week Range	1.360 - 2.440
Beta	0.28
RSI	64.30
Earnings Date	Mar 31, 2026

About LifeTech Scientific

LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders in Mainland China, Europe, Rest of Asia, India, South America, Africa, and internationally. It operates through Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac Pacing and Electrophysiology Business segments. The company’s products include LAmbre left atrial appendage closure systems, as well as CeraFlex, Cera, ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1999
• Employees: 1,276
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1302

Financial Performance

In 2025, LifeTech Scientific's revenue was 1.37 billion, an increase of 5.07% compared to the previous year's 1.30 billion. Earnings were 147.83 million, a decrease of -33.53%.

Financial numbers in CNY